CN107206019B - 用于治疗皮肤病症的次氯酸制剂和方法 - Google Patents

用于治疗皮肤病症的次氯酸制剂和方法 Download PDF

Info

Publication number
CN107206019B
CN107206019B CN201580076091.XA CN201580076091A CN107206019B CN 107206019 B CN107206019 B CN 107206019B CN 201580076091 A CN201580076091 A CN 201580076091A CN 107206019 B CN107206019 B CN 107206019B
Authority
CN
China
Prior art keywords
skin
formulation
hypochlorous acid
inflammatory
hocl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201580076091.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN107206019A (zh
Inventor
马克·桑普森
斯维特拉娜·潘彻瓦
凯瑞·肖克莫尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yogurt America Ltd.
Original Assignee
Yogurt America Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/572,378 external-priority patent/US9381214B2/en
Priority claimed from US14/670,641 external-priority patent/US9999635B2/en
Application filed by Yogurt America Ltd filed Critical Yogurt America Ltd
Publication of CN107206019A publication Critical patent/CN107206019A/zh
Application granted granted Critical
Publication of CN107206019B publication Critical patent/CN107206019B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
CN201580076091.XA 2014-12-16 2015-12-16 用于治疗皮肤病症的次氯酸制剂和方法 Active CN107206019B (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14/572,378 2014-12-16
US14/572,378 US9381214B2 (en) 2011-03-18 2014-12-16 Methods for treating skin irritation
US14/670,641 2015-03-27
US14/670,641 US9999635B2 (en) 2007-01-16 2015-03-27 Methods and compositions for treating inflammatory disorders
PCT/US2015/066147 WO2016100543A2 (fr) 2014-12-16 2015-12-16 Formulations d'acide hypochloreux et méthodes de traitement des maladies de peau

Publications (2)

Publication Number Publication Date
CN107206019A CN107206019A (zh) 2017-09-26
CN107206019B true CN107206019B (zh) 2021-09-24

Family

ID=56127847

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201580076091.XA Active CN107206019B (zh) 2014-12-16 2015-12-16 用于治疗皮肤病症的次氯酸制剂和方法

Country Status (12)

Country Link
US (1) US10987379B2 (fr)
EP (1) EP3233091A4 (fr)
JP (1) JP2017538755A (fr)
KR (1) KR20170095312A (fr)
CN (1) CN107206019B (fr)
AU (1) AU2015364697A1 (fr)
CA (1) CA2970804C (fr)
HK (1) HK1245641A1 (fr)
IL (1) IL252819A0 (fr)
MX (1) MX2017007852A (fr)
SG (1) SG11201704925WA (fr)
WO (1) WO2016100543A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9381214B2 (en) 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
US10485827B2 (en) 2016-01-19 2019-11-26 Rdg Holdings, Inc. Topical eye serum compositions, methods or preparing, and methods of use
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
SG11201912534SA (en) 2017-06-28 2020-01-30 Collidion Inc Compositions, methods and uses for cleaning, disinfecting and/or sterilizing
WO2019070920A1 (fr) * 2017-10-03 2019-04-11 Collidion, Inc. Compositions, méthodes et utilisations permettant d'améliorer une zone de peau ou de cheveux
KR20200123421A (ko) 2018-01-14 2020-10-29 콜리디온, 인코포레이티드 세척, 소독, 멸균 및/또는 치료를 위한 조성물, 키트, 방법 및 용도
EP3993811A1 (fr) * 2019-07-03 2022-05-11 Apr Applied Pharma Research S.A. Utilisations thérapeutiques de solutions acides oxydantes hypotoniques
TWI774263B (zh) * 2021-03-11 2022-08-11 英屬維京群島商白因子國際股份有限公司 次氯酸組合物及其應用
CN115067353A (zh) * 2021-03-11 2022-09-20 英属维尔京群岛商白因子国际股份有限公司 次氯酸组合物及次氯酸凝胶的制作方法
CN113082050A (zh) * 2021-04-26 2021-07-09 贵州扬生医用器材有限公司 一种妇科用温敏凝胶及其制备方法
EP4358977A1 (fr) * 2021-06-25 2024-05-01 TTD Global Pty Ltd Solutions stabilisées d'acide hypohaleux

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355190B (en) * 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
BRPI0609711B8 (pt) 2005-03-23 2021-05-25 Oculus Innovative Sciences Inc uso de uma solução aquosa com potencial redutivo oxidativo (orp)
US8147444B2 (en) 2006-01-20 2012-04-03 Oculus Innovative Sciences, Inc. Methods of treating or preventing peritonitis with oxidative reductive potential water solution
CN101405013A (zh) * 2006-01-20 2009-04-08 奥古露丝创新科学公司 使用氧化还原电位水溶液治疗或预防腹膜炎的方法
US20090305267A1 (en) 2006-05-03 2009-12-10 University Of Manitoba Microbial markers of inflammatory bowel disease
US8877257B2 (en) 2007-01-16 2014-11-04 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
US9999635B2 (en) 2007-01-16 2018-06-19 Realm Therapeutics, Inc. Methods and compositions for treating inflammatory disorders
KR20160121610A (ko) * 2008-04-01 2016-10-19 안티포딘 파마슈티칼스, 인코포레이티드 피부 관리를 위한 조성물 및 방법
WO2012129161A2 (fr) 2011-03-18 2012-09-27 Puricore, Inc. Solutions stabilisées d'acide hypohalogéneux
US9381214B2 (en) * 2011-03-18 2016-07-05 Puricore, Inc. Methods for treating skin irritation
US10617716B2 (en) 2014-12-16 2020-04-14 Urgo Us, Inc. Hypochlorous acid formulations and methods for treating skin conditions

Also Published As

Publication number Publication date
EP3233091A4 (fr) 2018-07-18
US10987379B2 (en) 2021-04-27
CN107206019A (zh) 2017-09-26
CA2970804A1 (fr) 2016-06-23
KR20170095312A (ko) 2017-08-22
AU2015364697A1 (en) 2017-07-13
EP3233091A2 (fr) 2017-10-25
US20200206263A1 (en) 2020-07-02
HK1245641A1 (zh) 2018-08-31
MX2017007852A (es) 2018-01-11
WO2016100543A2 (fr) 2016-06-23
CA2970804C (fr) 2023-01-31
SG11201704925WA (en) 2017-07-28
WO2016100543A3 (fr) 2016-08-18
JP2017538755A (ja) 2017-12-28
IL252819A0 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
CN107206019B (zh) 用于治疗皮肤病症的次氯酸制剂和方法
US10617716B2 (en) Hypochlorous acid formulations and methods for treating skin conditions
US20170360982A1 (en) Wound Healing Composition Involving Mineral Ions and Methylglyoxal, and Methods of Use
CA2762989C (fr) Prg4 pour traitement des troubles de lubrification des limites de la cavite buccale
ES2456502T3 (es) Composición que comprende PNC o PNB para un preparado externo para la piel para el tratamiento de la dermatitis
Sadeghian et al. Treatment of localized psoriasis with a topical formulation of zinc pyrithione
JP2022510377A (ja) 状態の処置のための組成物
CA2875052C (fr) Methode de traitement de maladies inflammatoires de la peau
US11241465B2 (en) Compositions and methods for skin treatments
JP5356802B2 (ja) 痒み抑制剤および痒み抑制組成物
ES2554332T3 (es) Utilización de la bencidamina en el tratamiento de las enfermedades dependientes de p40
US20220202853A1 (en) Hypohalous acids for treating inflammatory diseases and inhibiting growth of malignancies
Paravina et al. Pityriasis rubra pilaris: a report of two cases and literature review
Kim et al. Dermatology for the allergist
EP3980440A1 (fr) Agents anti-inflammatoires
JP7396585B2 (ja) Ｔｓｌｐ遺伝子発現抑制用、ｉｌ－３３遺伝子発現抑制用、又はフィラグリン産生促進用組成物
WO2019072353A1 (fr) Préparation pharmaceutique topique de bétaméthasone, de calcipotriol et d'huile de rose pour le traitement du psoriasis
JP2021510159A (ja) セルドゥラチニブ含有局所皮膚医薬組成物およびその使用
AU2022346513A1 (en) Gel composition for prevention or treatment of atopic dermatitis
Dyring‐Andersen The evolving regulatory role of ubiquitin-editing enzyme A20 in psoriasis during calcipotriol treatment.
EP3199151B1 (fr) Utilisation de l'acide chlorogénique dans la préparation d'un médicament indiqué pour le traitement du psoriasis
WO2019132850A1 (fr) Composés de traitement dermatologique et cosmétologique présentant des caractéristiques anti-inflammatoires et antiprurigineuses basées sur l'interaction de combinaisons de sels de strontium et réglisse utilisés comme adjuvants
Moccia et al. Review of oral psoriasis
JP2009161467A (ja) 痒み抑制剤および痒み抑制組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right

Effective date of registration: 20210209

Address after: American Texas

Applicant after: Yogurt America Ltd.

Address before: Pennsylvania, USA

Applicant before: REALM THERAPEUTICS, Inc.

TA01 Transfer of patent application right
GR01 Patent grant
GR01 Patent grant